Accelerating Global Access
Our company is collaborating with a range of partners to enable access for patients around the world
Published 12-13-21
Submitted by Merck & Co., Inc.
At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.
Here’s how we have been working to fulfill that commitment.
Merck & Co., Inc.
Merck & Co., Inc.
Today’s Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions.
We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.
More from Merck & Co., Inc.